COSMO Pharmaceuticals N.V.
Specialty pharma for gastroenterology/dermatology, offering colon treatments & manufacturing services.
COPN | SW
Overview
Corporate Details
- ISIN(s):
- NL0011832936
- LEI:
- 724500OX0EBQRYTVV639
- Country:
- Netherlands
- Address:
- Sir Rogerson's Quay Riverside II, Dublin 2 Dublin
- Website:
- https://www.cosmopharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
COSMO Pharmaceuticals N.V. is a specialty pharmaceutical company focused on developing and commercializing products for gastroenterology, dermatology, and healthtech. The company's therapeutic focus is on the oral and endoscopic treatment of colon diseases, including bowel diseases and colorectal cancer prevention, utilizing its proprietary MMX® technology. In addition to its own pipeline, Cosmo provides manufacturing services to other pharmaceutical companies. These services cover the production of solid, semi-solid, and liquid oral medicines and include process assessment, technology transfer, stability testing, market release, and regulatory documentation support.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-06-28 02:00 |
Cosmo gibt Zulassung von Cortiment® in Japan bekannt
|
German | 9.3 KB | ||
| 2023-06-22 02:00 |
Cosmo and Hyundai Pharm Announce Signing of License Agreement for Winlevi® in K…
|
English | 12.4 KB | ||
| 2023-06-22 02:00 |
Cosmo und Hyundai Pharm geben die Unterzeichnung einer Lizenzvereinbarung für W…
|
German | 13.5 KB | ||
| 2023-06-20 02:00 |
Cosmo Pharmaceuticals announces approval of Winlevi® in Canada
|
English | 10.9 KB | ||
| 2023-06-20 02:00 |
Cosmo Pharmaceuticals gibt die Zulassung von Winlevi® in Kanada bekannt
|
German | 11.7 KB | ||
| 2023-05-26 02:00 |
Cosmo Pharmaceuticals’ Shareholders approve all Agenda Items at Annual General …
|
English | 12.1 KB | ||
| 2023-05-26 02:00 |
Aktionärinnen und Aktionäre von Cosmo Pharmaceuticals stimmen an der Generalver…
|
German | 13.0 KB | ||
| 2023-03-30 02:00 |
Cosmo announces territory expansion agreement for Lumeblue™ (Methylene Blue MMX…
|
English | 12.7 KB | ||
| 2023-03-30 02:00 |
Cosmo kündigt Gebietserweiterungs-Vereinbarung für Lumeblue™ (Methylenblau MMX™…
|
German | 13.5 KB | ||
| 2023-03-23 01:00 |
Cosmo reports record 2022 financial results exceeding guidance,
increased divid…
|
English | 46.2 KB | ||
| 2023-03-23 01:00 |
Cosmo meldet Rekordergebnisse für 2022, welche die Prognosen übertreffen, erhöh…
|
German | 48.9 KB | ||
| 2023-03-22 01:00 |
Cosmo Pharmaceuticals announces that Cosmo Intelligent Medical Devices – IMD Lt…
|
English | 11.2 KB | ||
| 2023-03-22 01:00 |
Cosmo gibt bekannt, dass Cosmo Intelligent Medical Devices – IMD Ltd, eine hund…
|
German | 12.1 KB | ||
| 2023-03-16 01:00 |
Invitation to Cosmo’s full-year 2022 financial results and 2023 outlook webcast…
|
English | 8.2 KB | ||
| 2023-03-16 01:00 |
Einladung zur Webcast-Präsentation am 23. März zu den Ergebnissen 2022 und zum …
|
German | 8.6 KB |
Automate Your Workflow. Get a real-time feed of all COSMO Pharmaceuticals N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for COSMO Pharmaceuticals N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for COSMO Pharmaceuticals N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
